tiprankstipranks
Trending News
More News >
XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB)
NASDAQ:XTLB

XTL Biopharmaceuticals Sponsored ADR (XTLB) Revenue

Compare
115 Followers

XTL Biopharmaceuticals Sponsored ADR Revenue

XTL Biopharmaceuticals Sponsored ADR had a revenue of 289.00K in the quarter ending Dec 31, 2024, with 78.40%. This bring the company's revenue in the last twelve months to 451.00K, Decreased 178.40%. In the fiscal year ending Dec 31, 2024, XTL Biopharmaceuticals Sponsored ADR had annual revenue of 451.00K with Infinity% growth.
Revenue (ttm)
451.00K
Revenue Growth
P/S Ratio
16.66
Revenue/Employee
$45,100
Employees
10
Market Cap
$7.52M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
451.00K-45,100,000.00%
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016